Introduction: Non-typhi Salmonella species cause severe extra-intestinal focal infection after occult bacteremia. Although the number of cases of non-typhi salmonellosis is increasing worldwide among patients with immunocompromising conditions such as human immunodeficiency virus infection, infection is uncommon in immunocompetent subjects. We report a case of septic arthritis and bone abscess due to a rare non-typhi Salmonella organism that developed after a prolonged asymptomatic period. Case presentation: A 44-year-old Japanese immunocompetent man presented with acute-onset left knee pain and swelling. He had no history of food poisoning, and his most recent travel to an endemic area was 19 years ago. Salmonella enterica serovar Ohio was identified from samples of bone abscess and joint tissue. Arthrotomy and necrotic tissue debridement followed by intravenous ceftriaxone was successful.
Introduction
The non-typhi bacterium Salmonella enterica subspecies enterica serovar Ohio (Salmonella Ohio) is a rare human pathogen that can be acquired from livestock to cause zoonotic enterocolitis. Salmonellosis typically manifests as enterocolitis, with only rare extra-intestinal focal infections; the rates of osteomyelitis and septic arthritis due to Salmonella (typhi and non-typhi strains combined) are estimated to be less than 1% and 0.1% to 0.2% [1] , respectively. Despite the reports of several cases of enterocolitis due to Salmonella Ohio [2] [3] [4] , the only reported extraintestinal focal infection by this organism involved a soft tissue abscess [5] .
Even though the prevalence of non-typhi salmonellosis in humans is increasing worldwide among patients immunocompromised due to conditions such as human immunodeficiency virus (HIV) infection, non-typhi salmonellosis remains rare in immunocompetent subjects. Although Salmonella species easily enter the bloodstream and may cause focal salmonellosis after occult bacteremia, routine antimicrobial therapy of immunocompetent patients with only intestinal symptoms is considered unnecessary [6] .
Case presentation
We report the case of a 44-year-old Japanese man without any noteworthy medical history (including food poisoning) except for a right tibial fracture due to a traffic accident 30 years ago. His most recent foreign travel to an endemic area (Hong Kong) was 19 years ago, and he had not noticed any gastrointestinal symptoms during that trip. He is an office worker and has no contact with livestock animals. In June 2011, he suddenly developed left knee pain that gradually worsened and therefore visited our hospital. X-rays showed no apparent bone fractures, but an MRI revealed a high-intensity area on T2-weighted images that was suggestive of a femoral bone abscess ( Figure 1 ). Approximately 60mL of cloudy yellowish joint fluid was collected, and Salmonella (O:7 positive) was isolated. In vitro susceptibility testing by the broth microdilutionmethod using the MicroScan WalkAway 96SI system (Siemens, Germany) revealed susceptibility to ampicillin (minimal inhibitory concentration, <4μg/mL), amoxicillin-clavulanic acid (<8μg/mL), cefotaxime (<8μg/mL), imipenem (<1μg/mL), minocycline (2μg/mL), levofloxacin (<1μg/mL), and sulfamethoxazole-trimethoprim (<1μg/ mL). The strain also was susceptible to nalidixic acid (30μg), according to the disc method (Becton Dickinson, Cockyesville, MD, US). Blood cultures and an HIV test were both negative. Full-body computed tomography (CT) ruled out an aortic aneurysm. In light of the diagnosis of femoral abscess with septic arthritis and the results of in vitro susceptibility testing, therapy with a thirdgeneration cephalosporin (intravenous ceftriaxone 1g, once daily) was started.
On day 22 after presentation, he underwent arthrotomy and necrotic tissue resection. The synovium of his left knee joint was inflamed, and the distal end of his left femur contained multiple loculations that were filled with necrotic tissue. The necrotic tissue was debrided and the cavities filled with imipenem-loaded bone cement. Cultures of the necrotic tissue obtained during surgery grew O:7-positive Salmonella, as seen previously. To characterize the organism, we sent it to the Yokohama City Institute of Public Health for further analysis. The organism was classified as Salmonella enterica subspecies enterica serovar Ohio according to the serotype (6,7: b: l,w) assigned by using the Kauffmann-White scheme [7] based on agglutination with Salmonella O and H antigens (Denkaseiken, Tokyo, Japan). After postoperative rehabilitation, he was discharged on day 55 after presentation and received oral amoxicillin (500mg, four times daily) for six months in place of intravenous ceftriaxone.
Discussion
Cases of non-typhi salmonellosis in immunocompromised patients are increasing worldwide. Most of these cases are gastrointestinal and systemic infections, and additional complications remain rare. One of the few reports from countries in southeastern Asia suggested age older than 60 years and younger than 6 years as independent risk factors for non-typhi salmonellosis [8] ; another study from the same geographic region named age older than 50 years as a risk factor for the infectious vasculitis caused by non-typhi Salmonella [9] . Although food poisoning with Salmonella Ohio has occurred in Europe and Mexico [2] [3] [4] , the organism is more prevalent in southeastern Asia, but there have been no previous clinical reports of Salmonella Ohio infection in Japan. One report [10] suggested that food poisoning due to non-typhi Salmonella has a very low incidence in Japan. In that report, the incidences of Salmonella gastroenteritis in the ' Asia Pacific, High Income' and ' Asia, East' regions were estimated to be 32 and 3600 per 100,000 person-years, respectively [10] . This study assigned Japan to the ' Asia Pacific, High Income' region. Another report suggests that non-typhi salmonellosis (especially serotype D) was still prevalent in Hong Kong during 1982 to 1993 [11] . Our patient had no history of food poisoning, and his most recent travel to another endemic country occurred 19 years before presentation. Despite the lack of microbiologic confirmation of prior infection with Salmonella Ohio, oral infection at some point during his residence in Japan cannot be ruled out. In-depth discussion regarding his past medical history failed to reveal any probable source of the infection. We surmise that our patient had been infected asymptomatically at some point during the preceding 19 years and that the current joint and bone infection developed long after the primary incident. The reason for, and the duration of, the asymptomatic period are currently unknown and warrant further investigation.
Salmonella species enter the bloodstream readily, and blood cultures should be considered whenever Salmonella infections are suspected or diagnosed. Routine antibiotic therapy of immunocompetent patients with only gastrointestinal symptoms of salmonellosis currently is not considered to be necessary [6] . However, perhaps this therapy should be provided, given the possibility of late serious sequellae, as in our patient. A report from Taiwan showed that the nontyphi Salmonella serovar Choleraesuis has low susceptibility to quinolones; therefore, empiric treatment with a thirdgeneration cephalosporin should be considered [9] . In our patient, identifying the bacterial strain contributed to choosing the appropriate treatment for his bone infection.
Conclusions
We presented a case of septic arthritis and bone abscess due to a rare pathogen, Salmonella enterica serovar Ohio, in a 44year-old immunocompetent man with no recent history of travel abroad or food poisoning. Although routine antibiotic therapy of immunocompetent patients with gastrointestinal salmonellosis only is thought currently to be unnecessary, severe extra-intestinal focal infections can occur after a prolonged (for example, decades) asymptomatic period.
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